A settlement of a lawsuit with pharmacies and opioid manufacturers would mean about $362,000 a year for Skagit County substance abuse programs.
If the Skagit County Board Commissioners agrees to accept the settlement, the funding could be committed to county programs, Sarah Hinman, assistant director of county Public Health, said in a presentation Monday.
According to the terms of the settlement, this money will come annually for the next 17 years to states, cities and counties that signed on to the lawsuit. Nationwide, about $864 million will be distributed.
This suit was against manufacturers Allergen and Teva, as well as pharmacies Walmart, CVS and Walgreens, for their roles in producing and perpetuating the opioid epidemic. Suits against other companies are still pending.
Hinman said she will bring this issue back to the commissioners in a few weeks for their decision.
This is the second such settlement Skagit County has considered. In September, the commissioners agreed to a $181,000-a-year payment as part of a statewide settlement with three drug companies.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article.
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.